Brigitte T Huber Selected Research

Lyme Disease Vaccines

4/2009	HLA type and immune response to Borrelia burgdorferi outer surface protein a in people in whom arthritis developed after Lyme disease vaccination.
2/2004	An effective second-generation outer surface protein A-derived Lyme vaccine that eliminates a potentially autoreactive T cell epitope.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Brigitte T Huber Research Topics

Disease

15	Lyme Disease (Disease, Lyme) 07/2010 - 07/2002
9	Inflammation (Inflammations) 01/2017 - 07/2002
7	Infections 07/2010 - 07/2003
5	Arthritis (Polyarthritis) 12/2009 - 07/2003
2	Autoimmune Diseases (Autoimmune Disease) 01/2015 - 06/2005
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2015 - 09/2005
2	Genetic Predisposition to Disease (Genetic Predisposition) 07/2010 - 12/2009
2	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 03/2007 - 08/2005
2	Epstein-Barr Virus Infections 09/2006 - 08/2005
2	Myocarditis (Carditis) 11/2005 - 06/2005
1	Sepsis (Septicemia) 01/2017
1	Glomerulonephritis 01/2015
1	Anemia 01/2015
1	Atherosclerosis 01/2014
1	Fatigue 05/2013
1	Chronic Fatigue Syndrome (Myalgic Encephalomyelitis) 05/2013
1	Prostatic Neoplasms (Prostate Cancer) 12/2010
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 12/2010
1	Hyperinsulinism (Hyperinsulinemia) 12/2009
1	Glucose Intolerance 12/2009
1	Insulin Resistance 12/2009
1	Retinoblastoma (Glioblastoma, Retinal) 08/2009
1	Starvation 05/2009
1	Lymphoma (Lymphomas) 03/2009
1	Rheumatoid Arthritis 12/2008
1	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 09/2005
1	Rheumatic Diseases (Rheumatism) 09/2005
1	Disease Progression 07/2003

Drug/Important Bio-Agent (IBA)

7	OspA proteinIBA 12/2009 - 07/2003
6	CytokinesIBA 01/2017 - 07/2002
5	Anti-Bacterial Agents (Antibiotics)IBA 12/2009 - 07/2002
5	AntibodiesIBA 12/2008 - 07/2003
4	SuperantigensIBA 05/2013 - 09/2005
4	Proteins (Proteins, Gene)FDA Link 08/2009 - 08/2005
3	HLA-DR Antigens (HLA-DR)IBA 07/2010 - 12/2008
3	AntigensIBA 12/2009 - 06/2005
3	HLA-DRB1*04:01 antigenIBA 12/2009 - 07/2002
2	Membrane Proteins (Integral Membrane Proteins)IBA 07/2010 - 04/2007
2	VaccinesIBA 04/2009 - 02/2004
2	Lyme Disease VaccinesIBA 04/2009 - 02/2004
2	Lipoproteins (Lipoprotein)IBA 04/2007 - 03/2005
2	IntegrinsIBA 11/2005 - 06/2005
1	InflammasomesIBA 01/2017
1	Antinuclear AntibodiesIBA 01/2015
1	ApolipoproteinsIBA 01/2014
1	Apolipoproteins E (ApoE)IBA 01/2014
1	Interleukin-17 (Interleukin 17)IBA 01/2014
1	DNA (Deoxyribonucleic Acid)IBA 12/2010
1	Dipeptidyl-Peptidases and Tripeptidyl-PeptidasesIBA 12/2010
1	HLA-DRB1 Chains (HLA DRB1)IBA 12/2009
1	EnzymesIBA 12/2009
1	Glucagon-Like Peptide 1 (GLP 1)IBA 12/2009
1	Glucose (Dextrose)FDA LinkGeneric 12/2009
1	Cyclin DIBA 08/2009
1	ORALIT (ORS)IBA 04/2009
1	Tyrosine (L-Tyrosine)FDA Link 03/2009
1	Messenger RNA (mRNA)IBA 12/2008
1	Interferon-gamma (Interferon, gamma)IBA 12/2008
1	Immunoglobulin G (IgG)IBA 04/2007
1	Signaling Lymphocytic Activation Molecule Associated ProteinIBA 03/2007
1	LigandsIBA 08/2006
1	Keratins (Keratin)IBA 08/2006
1	AutoantigensIBA 08/2006
1	AutoantibodiesIBA 08/2006
1	CD18 AntigensIBA 11/2005
1	Chemotactic FactorsIBA 11/2005
1	Interferon-alpha (Interferon Alfa)IBA 09/2005
1	Immunodominant EpitopesIBA 06/2005
1	Toll-Like Receptors (Toll-Like Receptor)IBA 03/2005
1	ChemokinesIBA 03/2005
1	Chemokine ReceptorsIBA 03/2005
1	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 02/2004
1	ZymosanIBA 07/2003

Therapy/Procedure

2	Therapeutics 12/2008 - 07/2002
1	Bed Rest (Bedrest) 05/2013
1	Lasers (Laser) 03/2005
1	Synovectomy 03/2005